We selected top speakers both from academia and industry, to update you on the latest breakthroughs and newest technologies in this exciting and rapidly evolving field of life sciences. During this two-day event, specialists in the field are brought together, including:
Prashant Mali (UC San Diego, US): pioneer in the development of the CRIPR-Cas9 system for eukaryotic genome engineering and genome-wide screens. Dr. Mali is co-author of more than 45 peer-reviewed papers and holder of 5 patents.
Emily LeProust (CEO, Twist Bioscience): lead innovator of long-fragment DNA synthesis and co-founder of Twist Bioscience, a DNA synthesis company that raised already more than $200 million since its inception in 2013. Dr. LeProust is also co-author of more than 30 peer-reviewed papers and holder of more than 20 patents.
Mazhar Adli (University of Virginia, US): pioneer in applying CRISPR-Cas9 for epigenome editing, chromatin structure manipulation and dual-color chromatin imaging. His work on genome-wide mapping of aspecific binding sites of CRISPR/Cas9 (Nature Biotech, 2014) has been cited more than 150 times.
Peter Cameron (Senior Research Scientist, Caribou Biosciences): Caribou Biosciences pioneers in CRISPR-Cas genome editing to develop new medical therapies and bio-based products. Dr. Cameron recently published his work on SITE-Seq, a method to measure CRISPR-Cas9 specificity (Nature Methods, 2017).
Philipp Holliger (MRC Laboratory of Molecular Biology, UK): expert in synthetic biology to study the fundamental principles that shape artificial genetic systems and their evolution. His recent work on synthetic genetic polymers was featured in Scientific American’s 10 World Changing Ideas.
The conference program will hence immerse you in the greatest breakthroughs in the fields of genome engineering and synthetic biology, while there are also several networking opportunities, making it the perfect environment to set-up new collaborations.